US estrogen shortages widen to injections and creams
US estrogen shortages are widening beyond patches to include injections and vaginal creams as demand surges for hormone replacement therapy following the removal of a federal boxed warning.
Xurve View
Insights:
Xurve View
Women across the United States face a widening shortage of hormone replacement therapies as surging demand spills over from scarce patches into injectable and vaginal treatments. The shortages follow the removal of a long-standing boxed cancer warning on hormone therapy. Patients are increasingly seeking alternative treatments to manage menopause symptoms.
